GlycoMimetics, Inc.
GLYC
$0.2401
-$0.0346-12.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.84% | -11.41% | -16.17% | -7.84% | -8.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.64% | -41.70% | 15.99% | 1.59% | -9.62% |
| Operating Income | 44.58% | 41.70% | -15.99% | -1.59% | 9.71% |
| Income Before Tax | 20.44% | -6.76% | -22.24% | -3.64% | 11.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.44% | -6.76% | -22.24% | -3.64% | 11.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.44% | -6.76% | -22.24% | -3.64% | 11.38% |
| EBIT | 44.58% | 41.70% | -15.99% | -1.59% | 9.71% |
| EBITDA | 44.45% | 41.53% | -16.42% | -1.86% | 9.54% |
| EPS Basic | 20.57% | -6.57% | -21.87% | 2.97% | 27.09% |
| Normalized Basic EPS | 42.79% | 39.93% | -21.79% | 2.98% | 27.13% |
| EPS Diluted | 20.57% | -6.57% | -21.87% | 2.97% | 27.09% |
| Normalized Diluted EPS | 42.79% | 39.93% | -21.79% | 2.98% | 27.13% |
| Average Basic Shares Outstanding | 0.14% | 0.21% | 0.32% | 6.81% | 21.58% |
| Average Diluted Shares Outstanding | 0.14% | 0.21% | 0.32% | 6.81% | 21.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |